The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.
The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with ...
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical ...